TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29036554

Group type: EXPERIMENTAL
Intervention: Microwire assisted technique
Number of subjects: 212

Group type: COMPARATOR
Intervention: Contrast venography guided technique
Number of subjects: 212
Study: 27983686

Group type: EXPERIMENTAL
Intervention: 800 mg polyphenols derived from red wine and grape extracts in protein-rich beverages (dairy, soy)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 800 mg polyphenols derived from red wine and grape extracts in protein-free beverage
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (six gelatine capsules)
Number of subjects: 35
Study: 24965310

Group type: EXPERIMENTAL
Intervention: Obese subjects in fasting state
Number of subjects: 58

Group type: COMPARATOR
Intervention: Lean subjects in fasting state
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Obese subjects after food intake
Number of subjects: 58
Study: 22852210

Group type: EXPERIMENTAL
Intervention: Contra-lateral needling
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 106

Group type: COMPARATOR
Intervention: Non-acupuncture
Number of subjects: 106
Study: 20434015

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 18285548

Group type: EXPERIMENTAL
Intervention: Maribavir 100 mg twice daily
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Maribavir 400 mg once daily
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Maribavir 400 mg twice daily
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Maribavir
Number of subjects: 111
Study: 16173886

Group type: EXPERIMENTAL
Intervention: Alcohol cues
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Alcohol cues with unavailability information
Number of subjects: 134

Group type: COMPARATOR
Intervention: Neutral cues
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Alcohol cues with availability information
Number of subjects: 134
Study: 15624040

Group type: EXPERIMENTAL
Intervention: Fluvastatin 80 mg/day (n = 30)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 43
Study: 11715353

Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg/day
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg/day
Number of subjects: 732

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Vitamin E 400 IU/day
Number of subjects: 732
Study: 9143445

Group type: EXPERIMENTAL
Intervention: Patients with a lesion in the occipitotemporal cortex, superior temporal cortex, and frontal cortex
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Patients with damage in the anterior inferotemporal cortex
Number of subjects: 23

Group type: COMPARATOR
Intervention: Age-matched volunteers
Number of subjects: 23
Study: 7989424

Group type: EXPERIMENTAL
Intervention: Angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 0
Study: 3619222

Group type: EXPERIMENTAL
Intervention: Verapamil during low-sodium diet (9 meq/d)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Verapamil during high-sodium diet (212 meq/d)
Number of subjects: 13
Study: 29153754

Group type: EXPERIMENTAL
Intervention: Combined activity program (90-minute sessions weekly for 40 weeks)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Health education program (90-minute classes thrice during the 40-week trial)
Number of subjects: 308
Study: 28334708

Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 10
Study: 25302753

Group type: EXPERIMENTAL
Intervention: Primary care follow-up
Number of subjects: 189

Group type: COMPARATOR
Intervention: HF clinic follow-up
Number of subjects: 189
Study: 23866725

Group type: EXPERIMENTAL
Intervention: Hydrotherapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Rest in bed (Control)
Number of subjects: 34
Study: 21876572

Group type: EXPERIMENTAL
Intervention: 0.5 ml/kg of 0.25 % bupivacaine with 1 mg/kg of tramadol (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.5 ml/kg of 0.25 % bupivacaine (Group A)
Number of subjects: 40
Study: 19015485

Group type: EXPERIMENTAL
Intervention: MK-677 25 mg
Number of subjects: 563

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 563
Study: 16731091

Group type: EXPERIMENTAL
Intervention: Infected black women who received CDC recommended treatment
Number of subjects: 1038

Group type: EXPERIMENTAL
Intervention: Infected black women
Number of subjects: 1038

Group type: EXPERIMENTAL
Intervention: Presence of bacterial vaginosis, T vaginalis, or C trachomatis
Number of subjects: 1038

Group type: COMPARATOR
Intervention: Uninfected black women
Number of subjects: 1038
Study: 12730989

Group type: EXPERIMENTAL
Intervention: Unilateral GPi pallidotomy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 36
Study: 11049909

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Atropine 5 microg/kg (small-dose)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Atropine 10 microg/kg (large-dose)
Number of subjects: 75
Study: 8615503

Group type: EXPERIMENTAL
Intervention: Tizanidine 12 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Clonidine 150 micrograms
Number of subjects: 6
Study: 1397667

Group type: EXPERIMENTAL
Intervention: Vivida (500 mg/day for 90 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Imedeen (380 mg/day for 90 days)
Number of subjects: 30
Study: 3898418

Group type: EXPERIMENTAL
Intervention: Nalbuphine 20 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pethidine 100 mg
Number of subjects: 60
Study: 30282398

Group type: EXPERIMENTAL
Intervention: Caudal approach
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: S1 foraminal approach
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: L5-S1 transforaminal approach
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups (caudal, S1 foraminal, L5-S1 transforaminal)
Number of subjects: 60
Study: 26996246

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS up-titration from 30 mg to 60 mg
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Valsartan up-titration from 80 mg to 160 mg
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Low-dose combination of Nifedipine GITS (30 mg) and Valsartan (80 mg)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Low-dose monotherapy of Nifedipine GITS (30 mg)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Low-dose monotherapy of Valsartan (80 mg)
Number of subjects: 362
Study: 25275672

Group type: EXPERIMENTAL
Intervention: Topiramate (100 mg, oral, twice daily, titrated over 2 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 22527079

Group type: EXPERIMENTAL
Intervention: Levosimendan (0.1 μg/kg/min continuous infusion for 72 hours)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard post‐CPB inotrope infusion
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 63
Study: 20008998

Group type: COMPARATOR
Intervention: Embryonic dopamine cell implantation
Number of subjects: 33
Study: 18525288

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (educational support or entertainment activities)
Number of subjects: 59
Study: 16135979

Group type: EXPERIMENTAL
Intervention: Bone Seal
Number of subjects: 112

Group type: COMPARATOR
Intervention: Collagen fleece (Lyostypt)
Number of subjects: 112
Study: 12746365

Group type: EXPERIMENTAL
Intervention: Arm A intervention (3 clinical problems: cardiovascular topics, upper and lower abdominal complaints)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Arm B intervention (3 clinical problems: chronic obstructive pulmonary disease, asthma, general complaints, degenerative joint complaints)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Arm A control (for problems allocated to arm B)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Arm B control (for problems allocated to arm A)
Number of subjects: 174
Study: 10373872

Group type: EXPERIMENTAL
Intervention: Questionnaire administered on the second postnatal day
Number of subjects: 615
Study: 7718101

Group type: EXPERIMENTAL
Intervention: Chilled cabbage leaves
Number of subjects: 34

Group type: COMPARATOR
Intervention: Chilled gelpaks
Number of subjects: 34
Study: 2201759

Group type: EXPERIMENTAL
Intervention: Subgingival irrigation with 0.12% CHX and daily marginal irrigation with 0.04% CHX
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Subgingival irrigation with 0.12% CHX and daily marginal irrigation with water
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Subgingival and daily marginal irrigation with water
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non‐irrigation (control)
Number of subjects: 60
Study: 7024807

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 41
Study: 31713774

Group type: EXPERIMENTAL
Intervention: Selenium (Se) treatment at 50 to 200 nmol/L
Number of subjects: 7

Group type: COMPARATOR
Intervention: LPS treatment (only LPS)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Selenium (Se) treatment with LPS (LS50 to LS200)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Selenium (Se) treatment at 50 to 100 nmol/L
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Selenium (Se) treatment
Number of subjects: 7
Study: 30203546

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercises (3 days per week for 8 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 44
Study: 28407007

Group type: EXPERIMENTAL
Intervention: Triple therapy (omeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, each twice daily) plus polaprezinc 75 mg twice daily (Arm A)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Triple therapy (omeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, each twice daily) plus polaprezinc 150 mg twice daily (Arm B)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Triple therapy alone (Arm C)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Arm B (Triple therapy plus polaprezinc 150 mg)
Number of subjects: 303
Study: 26286610

Group type: EXPERIMENTAL
Intervention: 0.1% Mometasone Furoate Cream (MF) in combination with LA-Cer moisturizer
Number of subjects: 106

Group type: COMPARATOR
Intervention: 0.1% Mometasone Furoate Cream (MF)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: LA-Cer-MF
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: LA-Cer-group (T2)
Number of subjects: 106
Study: 24220723

Group type: EXPERIMENTAL
Intervention: The Integrated Skin Exam film
Number of subjects: 8
Study: 20923378

Group type: EXPERIMENTAL
Intervention: Prototype colonoscope with graded flaccidity
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Prototype colonoscope with ungraded flaccidity
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Prototype group (both graded and ungraded)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard group
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Prototype group
Number of subjects: 400
Study: 20015319

Group type: EXPERIMENTAL
Intervention: Drotrecogin alpha (activated) (DAA)
Number of subjects: 3348

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3348
Study: 17408389

Group type: EXPERIMENTAL
Intervention: Heavy silicone oil (Densiron(R))
Number of subjects: 700

Group type: COMPARATOR
Intervention: Standard silicone oil (1000 cSt or 5000 cSt)
Number of subjects: 700
Study: 15103194

Group type: EXPERIMENTAL
Intervention: Laryngeal electromyography (EMG)
Number of subjects: 35
Study: 11409683

Group type: EXPERIMENTAL
Intervention: Silicone mouthguard
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Acrylic mouthguard
Number of subjects: 52
Study: 11094038

Group type: EXPERIMENTAL
Intervention: Continuous infusion of prostacyclin in 15 patients with PPH and 3 with sPAH.
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (healthy subjects).
Number of subjects: 105
Study: 8659199

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg/day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg/day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate 80 mg/day
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 1644341

Group type: EXPERIMENTAL
Intervention: Nasal oxygen supplementation (2 l/min)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Minimal midazolam sedation alone (Control)
Number of subjects: 66
Study: 6240785

Group type: EXPERIMENTAL
Intervention: Thiamphenicol (2.5 g perorally)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Aqueous procaine penicillin G (4.8 X 10(6) units im) plus probenecid (1 g perorally)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Spectinomycin (2 g im)
Number of subjects: 370
Study: 31439584

Group type: EXPERIMENTAL
Intervention: osimertinib
Number of subjects: 556

Group type: COMPARATOR
Intervention: Comparator EGFR-TKI
Number of subjects: 556
Study: 29384839

Group type: EXPERIMENTAL
Intervention: 2-thumbs-fist technique (nTTT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: 2-finger technique (TFT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: 2-thumb-encircling hands technique (TTEHT)
Number of subjects: 63
Study: 26813849

Group type: EXPERIMENTAL
Intervention: 60 once-daily pills after each donation (19 mg of iron)
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: 60 once-daily pills after each donation (38 mg of iron)
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Iron status information letter after each donation
Number of subjects: 692

Group type: COMPARATOR
Intervention: Placebo pills
Number of subjects: 692

Group type: COMPARATOR
Intervention: No information letter
Number of subjects: 692
Study: 25664051

Group type: EXPERIMENTAL
Intervention: Vitamin D oral supplementation (45000 IU/week for 2 months and a single 45000 IU in the last month)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 23130536

Group type: EXPERIMENTAL
Intervention: Transoral robot‐assisted lingual tonsillectomy with uvulopalatopharyngoplasty
Number of subjects: 20
Study: 20125103

Group type: EXPERIMENTAL
Intervention: Protein-rich breakfast (PR) - 48g protein
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Normal-protein breakfast (PN) - 18g protein
Number of subjects: 13

Group type: COMPARATOR
Intervention: Breakfast skipping (BS)
Number of subjects: 13
Study: 18410902

Group type: EXPERIMENTAL
Intervention: Intravenous busulfan 130 mg/m(2) once daily x 4 days and fludarabine 40 mg/m(2) daily x 4 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 10
Study: 15741746

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 24
Study: 12429757

Group type: EXPERIMENTAL
Intervention: Group 1: Sequential transection of the triangular fibrocartilage complex and the interosseous membrane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Group 2: Sequential transection of the interosseous membrane and the triangular fibrocartilage complex
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups: Transection of both the triangular fibrocartilage complex and the interosseous membrane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups after load removal
Number of subjects: 12
Study: 10339471

Group type: EXPERIMENTAL
Intervention: Prophylactic inhalations with aerosolized amphotericin B (aeroAmB) at a dose of 10 mg twice daily
Number of subjects: 382

Group type: COMPARATOR
Intervention: No inhalation prophylaxis
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Prophylactic inhalations with aerosolized amphotericin B (aeroAmB)
Number of subjects: 382
Study: 7499945

Group type: EXPERIMENTAL
Intervention: Beclomethasone nasal spray (Beconase) applied to one nostril for six weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control nostril (untreated)
Number of subjects: 29
Study: 1959515

Group type: EXPERIMENTAL
Intervention: Dutch dietary guidelines diet (G)
Number of subjects: 12
Study: 31099485

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) treatment
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Active disease
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: MTX therapy
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: MTX cumulative dose
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: MTX treatment duration
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Disease activity
Number of subjects: 49

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 49
Study: 29389510

Group type: EXPERIMENTAL
Intervention: Nutrition intervention integrating motivational interviewing, active learning, and applied problem solving to increase whole plant food intake
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Nutrition intervention
Number of subjects: 136
Study: 26291745

Group type: EXPERIMENTAL
Intervention: Posterior left atrial wall plication (T‐plasty)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No left atrial size reduction (Control Group)
Number of subjects: 60
Study: 25431865

Group type: EXPERIMENTAL
Intervention: L-DNR/FLAG (liposomal daunorubicin, fludarabine, cytarabine, G-CSF)
Number of subjects: 155

Group type: COMPARATOR
Intervention: FLAG only
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: L-DNR/FLAG
Number of subjects: 155
Study: 22633893

Group type: COMPARATOR
Intervention: Spinal Anesthesia (SA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 60
Study: 20332741

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 3350
Study: 17277603

Group type: EXPERIMENTAL
Intervention: Action Schools! BC (AS! BC) intervention
Number of subjects: 287

Group type: COMPARATOR
Intervention: Usual practice (UP)
Number of subjects: 287
Study: 15676064

Group type: COMPARATOR
Intervention: Full vacuum suction drainage (pressure = 700 g/m2)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Half vacuum suction drainage (pressure = 350 g/m2)
Number of subjects: 85
Study: 12018455

Group type: EXPERIMENTAL
Intervention: Stapled Longo procedure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Milligan-Morgan hemorrhoidectomy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 80
Study: 9988403

Group type: EXPERIMENTAL
Intervention: Three-dimensional partial zona dissection
Number of subjects: 340

Group type: COMPARATOR
Intervention: Conventional partial zona dissection
Number of subjects: 340
Study: 7752591

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg/day
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 2098653

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/daily)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 6986242

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (2 tablets twice daily)
Number of subjects: 41
Study: 30793177

Group type: EXPERIMENTAL
Intervention: Vitamin D 3 (250,000 IU single dose followed by 50,000 IU every other week)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo (identically matched placebo pill)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Vitamin D 3
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 27632839

Group type: EXPERIMENTAL
Intervention: Balance Training with STARS (BTS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Balance Training (BT)
Number of subjects: 24
Study: 26159020

Group type: EXPERIMENTAL
Intervention: CHSQABC + routine Western medicine treatment (Xinyue Capsule: 2 pills, 3 times/day; Compound Chuanxiong Capsule: 2 pills, 3 times/day for half a year)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Routine Western medicine treatment (control group)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: CHSQABC + routine Western medicine treatment
Number of subjects: 281
Study: 24354904

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Left lateral decubitus position
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Right lateral decubitus position
Number of subjects: 16
Study: 21995296

Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RelyX ARC
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cement-Post
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MaxCem
Number of subjects: 90

Group type: COMPARATOR
Intervention: Post configurations (parallel‐sided and serrated vs tapered and smooth)
Number of subjects: 90
Study: 20415263

Group type: EXPERIMENTAL
Intervention: Cycloferon (exact dosage not specified)
Number of subjects: 0
Study: 15899447

Group type: EXPERIMENTAL
Intervention: Aspheric Tecnis IOL (Pfizer/Pharmacia Tecnis Z9000)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional AcrySof IOL (Alcon AcrySof SA60AT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aspheric Tecnis IOL
Number of subjects: 60
Study: 12673423

Group type: EXPERIMENTAL
Intervention: Roux-en-y esophagojejunostomy (r-y)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Roux-en-y with pouch (p-y)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Jejunal interposition with pouch (p-i)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 11021706

Group type: EXPERIMENTAL
Intervention: Labial flap approach
Number of subjects: 10

Group type: COMPARATOR
Intervention: Crestal incision approach
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 10
Study: 8927663

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 1800749

Group type: EXPERIMENTAL
Intervention: Philips 5306B electronic manometer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hawksley random zero mercury manometer
Number of subjects: 0